Why the study?
Does C-type natriuretic peptide inhibit pathological differentiation of valvular interstitial cells in calcific aortic valve disease models?
Population
Porcine aortic valves (normal and sclerotic) and in vitro valvular interstitial cells (VICs)
Comparison
C-type natriuretic peptide (CNP) and simvastatin vs Control culture conditions
Design
Preclinical
Authors
Loading...
CNP pathway merits exploration as antifibrotic target in aortic valve disease; leaves open in vivo and human validation.
Does C-type natriuretic peptide inhibit pathological differentiation of valvular interstitial cells in calcific aortic valve disease models?
CNP protects against calcific aortic valve disease by inhibiting pathological differentiation of valvular interstitial cells, a mechanism that also partially explains the pleiotropic effects of statins.
Yip et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: